Abstract
ABSTRACT: To study the effects of peroxisome proliferators on fetal biogenesis, 400 mg/kg oral clofibrate was administered to pregnant mice beginning at d 6 of gestation. Maternal/fetal tissues from three separate experiments were harvested between gestational d 13 and 19 and maternal/fetal tissues were assayed for peroxisomal matrix, membrane-associated, and integral membrane proteins. By comparison to control pregnancies that received vehicle only, clofibrate produced a 4− to 5-fold increase in the levels of peroxisomal membrane protein 70, a 1.5− to 2-fold increase of dihydroxyacetone phosphate acyltransferase (DHAP-AT) sp act, and a 1.2− to 1.8-fold increase of catalase sp act in fetal liver of 19 d gestation. Fetal liver endoplasmic reticulum and peroxisomes were also amplified as visualized by electron microscopy. Clofibrate exhibited maximal effects on maternal tissues by 6 d of oral treatment with increases in peroxisomal membrane protein 70 occurring most clearly in maternal liver; DHAP-AT activity was increased in maternal liver, kidney, and brain but not in lung. Slight increases in DHAP-AT activities were evident in fetal brain, lung, and placenta as compared with the greater increases in liver and kidney. There was a general increase in peroxisomal proteins between 13 and 19 gestational d in all fetal tissues except placenta, and the effect of clofibrate was evident by gestational d 13 in lung and placenta. Minimal changes in the activities of acid phosphatase (lysosomal enzyme) or glycerol-3-phosphate acyltransferase (microsomal enzyme) were observed in maternal or fetal tissues although the latter enzyme was increased 10–30% by clofibrate in maternal brain, fetal lung, and placenta. The degree of amplification peroxisomal membrane portion 70 > DHAP-AT > catalase observed in several tissues after clofibrate treatment is consistent with a similar order in the sequence of peroxisomal assembly. The ability to manipulate fetal peroxisomes by maternal pharmacology provides a potentially useful system for studying the regulation of peroxisomal biogenesis.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, G., King, T., Argyle, J. et al. Maternal Clofibrate Administration Amplifies Fetal Peroxisomes. Pediatr Res 29, 256–262 (1991). https://doi.org/10.1203/00006450-199103000-00007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199103000-00007